Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bailey Set To Assume HIMA Presidency Following June 10 Board Meeting

This article was originally published in The Gray Sheet

Executive Summary

The Health Industry Manufacturers Association is underscoring the experience of its incoming president, Pamela Bailey, in building coalitions around specific health-related issues, indicating the direction of the medical device trade group's Washington lobbying effort in the near future.

You may also be interested in...



HIMA Changes Name To AdvaMed As Group Intensifies Hill Lobbying Effort

The Health Industry Manufacturers Association's name change to the Advanced Medical Technology Association (AdvaMed) comes as the organization ramps up a high-profile Medicare reform lobbying effort on Capitol Hill that likely will spill over into the upcoming presidential election.

HIMA Changes Name To AdvaMed As Group Intensifies Hill Lobbying Effort

The Health Industry Manufacturers Association's name change to the Advanced Medical Technology Association (AdvaMed) comes as the organization ramps up a high-profile Medicare reform lobbying effort on Capitol Hill that likely will spill over into the upcoming presidential election.

FDA Committed To Third-Party Review, Henney Tells Senate HELP Committee

FDA Commissioner Jane Henney is "puzzled" about the low utilization rate within the device industry of the agency's "Accredited Persons" third-party premarket review program, she said at an Oct. 21 Senate Health, Education, Labor and Pensions Committee hearing.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel